IIL setting up animal vax facility in Genome Valley

Biotech player Indian Immunologicals Limited (IIL) is setting up a greenfield veterinary vaccines manufacturing facility in Genome Valley, Hyderabad, at an investment of 700 crore.
The new facility, which will create over 750 direct and indirect jobs, will manufacture Foot and Mouth Disease vaccine (FMD-Vac) as well as a combination Foot and Mouth Disease and Haemorrhagic Septicaemia vaccine (FMD+HS-Vac), the company said.
The upcoming facility will have a capacity to produce 300 million doses per annum, with 150 million doses per annum each of the two vaccines.
IIL said the greenfield vaccine manufacturing facility will be equipped with a BSL-3 facility for manufacturing drug substances as well as a fill-finish capability for the production of drug products for the two animal vaccines.
The facility is coming up on a 14-acre plot in Phase III of the Telangana State Industrial Infrastructure Corporation Ltd’s Biotech Park at Karkapatla in Siddipet district.
National Dairy Development Board and IIL chairman Meenesh Shah, who led the ground-breaking ceremony, said, “IIL’s ability to discover and manufacture affordable vaccines has saved the exchequer several thousand crores of rupees.”
IIL managing director Dr K Anand Kumar, said the company is in an exponential growth phase and expected to grow 40% this year alone.
“In order to sustain the momentum, IIL is seriously considering making additional investments in building infrastructure within India and in other emerging geographies including Africa in a manner to develop tools that will help in control and eradication of diseases,” Anand Kumar said.
Source: Timesofindia